Derma Sciences, Inc. DSCI
7.00 0.00 (+0.00%)
At closeJun 28, 2019, 6:07 PM EDT
6.96 Day range 7.05
2.92 52-week range 7.05
News
businesswire.com Derma Sciences Reports 2016 Third Quarter Financial Results PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
businesswire.com Derma Sciences Reports 2016 Second Quarter Financial Results PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
businesswire.com Derma Sciences to Acquire BioD, Solidify Its Leadership Position in
Advanced Wound Care and Regenerative Products PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announces the signing of a definitive agreement to acquire…
businesswire.com Derma Sciences Reports 2016 First Quarter Financial Results PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
businesswire.com Derma Sciences Reports 2015 Fourth Quarter and Full Year Financial
Results PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
businesswire.com Derma Sciences to Hold Conference Call on November 12 to Discuss Data
Monitoring Committee Pre-Specified Interim Analysis of the Aclerastide
Phase 3 Trials PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, will issue a news release at 7:30 a.m. Eastern time on…
businesswire.com Derma Sciences Reports Third Quarter 2015 Financial Results PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
businesswire.com CORRECTING and REPLACING Derma Sciences Reports Second Quarter
Financial Results PRINCETON, N.J.--(BUSINESS WIRE)--In the Management Commentary section, fifth graph, last sentence should read: We continue to expect full-year sales of $43.8 million for the TWC business in 2015,”…
businesswire.com Derma Sciences Reports First Quarter 2015 Financial Results PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
businesswire.com Derma Sciences Reports Fourth Quarter and Year Ended Financial Results PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
businesswire.com Derma Sciences Reports Third Quarter Financial Results PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
businesswire.com Derma Sciences Reports Second Quarter Financial Results PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
businesswire.com Derma Sciences Reports First Quarter Financial Results PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
businesswire.com Derma Sciences Reports Fourth Quarter Financial Results, Provides
Commercial Update Including Sales Force Expansion and Progress in
Launching New Placental-Derived Tissue Products PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (the “Company”) (Nasdaq:DSCI), a tissue regeneration and burn care company focused on advanced wound care, today reported financial and…
benzinga.com Earnings Scheduled For March 29